Delifab
Board
1 director, no change since 2025Director, permanent representative
since 21-01-2021
also on the board of 1 other company
listed in the 2026 annual accounts, filed on 29-10-2026
Permanent representatives 1
Mandates through the years
1 name, the dashed line is todayDirector
Board
Mandates as a list
-
- Director, from 21-01-2021 to date
With Starter you also see 1 former office holder in the mandate history.
See the plans →
Control
Founder
This company
Delifab
Equity €239,819
Profit €45,643 in 2026
Capital
- Contribution
- €20,000
- Shares
- 200
- Contribution per share
- €100
- Equity per share
- €1,199 in 2026
- Source
- deed of 25-01-2021
Articles of association
deed of 25-01-2021 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- “Titel V - Algemene vergadering Artikel 16. Organisatie en bijeenroeping Ieder jaar wordt een gewone algemene vergadering van aandeelhouders…”
Shareholders
At incorporation
deed of 25-01-2021 ↗
- 2,000 shares · €20,000